Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.
Mol Cancer Ther
; 13(2): 364-74, 2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-24356814
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Xenograft Model Antitumor Assays
/
P38 Mitogen-Activated Protein Kinases
/
Imidazoles
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2014
Document type:
Article
Country of publication:
Estados Unidos